Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Glia maturation factor expression in hippocampus of human Alzheimer's disease.

Stolmeier D, Thangavel R, Anantharam P, Khan MM, Kempuraj D, Zaheer A.

Neurochem Res. 2013 Aug;38(8):1580-9. doi: 10.1007/s11064-013-1059-3. Epub 2013 May 3.

2.

Glia maturation factor expression in entorhinal cortex of Alzheimer's disease brain.

Thangavel R, Kempuraj D, Stolmeier D, Anantharam P, Khan M, Zaheer A.

Neurochem Res. 2013 Sep;38(9):1777-84. doi: 10.1007/s11064-013-1080-6. Epub 2013 May 29.

3.

Expression of glia maturation factor in neuropathological lesions of Alzheimer's disease.

Thangavel R, Stolmeier D, Yang X, Anantharam P, Zaheer A.

Neuropathol Appl Neurobiol. 2012 Oct;38(6):572-81. doi: 10.1111/j.1365-2990.2011.01232.x.

4.

Alzheimer's disease: evidence for the expression of interleukin-33 and its receptor ST2 in the brain.

Xiong Z, Thangavel R, Kempuraj D, Yang E, Zaheer S, Zaheer A.

J Alzheimers Dis. 2014;40(2):297-308. doi: 10.3233/JAD-132081.

5.

Augmented expression of glia maturation factor in Alzheimer's disease.

Zaheer S, Thangavel R, Sahu SK, Zaheer A.

Neuroscience. 2011 Oct 27;194:227-33. doi: 10.1016/j.neuroscience.2011.07.069. Epub 2011 Aug 2.

6.

Enhanced expression of glia maturation factor correlates with glial activation in the brain of triple transgenic Alzheimer's disease mice.

Zaheer S, Thangavel R, Wu Y, Khan MM, Kempuraj D, Zaheer A.

Neurochem Res. 2013 Jan;38(1):218-25. doi: 10.1007/s11064-012-0913-z. Epub 2012 Oct 20.

8.

Glia maturation factor modulates beta-amyloid-induced glial activation, inflammatory cytokine/chemokine production and neuronal damage.

Zaheer A, Zaheer S, Thangavel R, Wu Y, Sahu SK, Yang B.

Brain Res. 2008 May 7;1208:192-203. doi: 10.1016/j.brainres.2008.02.093. Epub 2008 Mar 10.

9.

Increased 5-lipoxygenase immunoreactivity in the hippocampus of patients with Alzheimer's disease.

Ikonomovic MD, Abrahamson EE, Uz T, Manev H, Dekosky ST.

J Histochem Cytochem. 2008 Dec;56(12):1065-73. doi: 10.1369/jhc.2008.951855. Epub 2008 Aug 4.

10.

Evidence for the association of protein 4.1 immunoreactive forms with neurofibrillary tangles in Alzheimer's disease brains.

Sihag RK, Wang LW, Cataldo AM, Hamlin M, Cohen CM, Nixon RA.

Brain Res. 1994 Sep 5;656(1):14-26.

PMID:
7804827
11.
12.

Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease.

Streit WJ, Braak H, Xue QS, Bechmann I.

Acta Neuropathol. 2009 Oct;118(4):475-85. doi: 10.1007/s00401-009-0556-6. Epub 2009 Jun 10.

13.
14.

Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases.

Sasaki N, Fukatsu R, Tsuzuki K, Hayashi Y, Yoshida T, Fujii N, Koike T, Wakayama I, Yanagihara R, Garruto R, Amano N, Makita Z.

Am J Pathol. 1998 Oct;153(4):1149-55.

15.

A novel role of glia maturation factor: induction of granulocyte-macrophage colony-stimulating factor and pro-inflammatory cytokines.

Zaheer A, Zaheer S, Sahu SK, Knight S, Khosravi H, Mathur SN, Lim R.

J Neurochem. 2007 Apr;101(2):364-76. Epub 2007 Jan 22.

16.

Loss of nonphosphorylated neurofilament immunoreactivity in temporal cortical areas in Alzheimer's disease.

Thangavel R, Sahu SK, Van Hoesen GW, Zaheer A.

Neuroscience. 2009 May 5;160(2):427-33. doi: 10.1016/j.neuroscience.2009.02.037. Epub 2009 Feb 27.

17.

Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer's disease and in age-matched controls.

Han SH, Hulette C, Saunders AM, Einstein G, Pericak-Vance M, Strittmatter WJ, Roses AD, Schmechel DE.

Exp Neurol. 1994 Jul;128(1):13-26.

PMID:
8070517
18.

Memory performance is related to amyloid and tau pathology in the hippocampus.

Reitz C, Honig L, Vonsattel JP, Tang MX, Mayeux R.

J Neurol Neurosurg Psychiatry. 2009 Jul;80(7):715-21. doi: 10.1136/jnnp.2008.154146. Epub 2009 Mar 3.

19.

Application of triple immunohistochemistry to characterize amyloid plaque-associated inflammation in brains with Alzheimer's disease.

Dandrea MR, Reiser PA, Gumula NA, Hertzog BM, Andrade-Gordon P.

Biotech Histochem. 2001 Mar;76(2):97-106.

PMID:
11440311
20.

Phosphatidylinositol-4,5-bisphosphate is enriched in granulovacuolar degeneration bodies and neurofibrillary tangles.

Nishikawa T, Takahashi T, Nakamori M, Yamazaki Y, Kurashige T, Nagano Y, Nishida Y, Izumi Y, Matsumoto M.

Neuropathol Appl Neurobiol. 2014 Jun;40(4):489-501. doi: 10.1111/nan.12056.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk